Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/11916237

Download in:

View as

General Info

PMID
11916237